Rise and shine. Another day is on the way. Here on the chilly Pharmalot corporate campus, we are doing our best to scurry the short people off to their school houses. As always, this ritual calls for a cup or two of stimulation. Please join us - or grab a bottle of water, whatever you fancy - as we indulge and scan the news of the world. Hope your day goes well...
Pfizer Ends Drug Development Deal With Adolor (Reuters)
Novartis Moves Infectious Disease Unit From Massachusetts (SF Business Times)
Pfizer Recalls More Bottles Of 40 mg Lipitor (Associated Press)
Novartis Pill For Advanced MS May Be A $5B Blockbuster (Bloomberg News)
Greece Sets Generic Pricing (Pharma Times)
Pfizer Settles Two Prempro Cases (Reno Gazette-Journal)
AstraZeneca Takes $445M Charge On Failure Of RSV Drug (Bloomberg News)